The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of γ-Herpesvirus Infected B Cells in the Marmoset EAE Model

Fast Progression of Recombinant Human Myelin/Oligodendrocyte Glycoprotein (MOG)-Induced Experimental Autoimmune Encephalomyelitis in Marmosets Is Associated with the Activation of MOG34-56-Specific Cytotoxic T Cells

(2014) Y. S. Kap et al.   JOURNAL OF IMMUNOLOGY

Antibodies Against Human BLyS and APRIL Attenuate EAE Development in Marmoset Monkeys

(2012) S. Anwar Jagessar et al.   Journal of Neuroimmune Pharmacology

B-Cell Depletion Abrogates T Cell-Mediated Demyelination in an Antibody-Nondependent Common Marmoset Experimental Autoimmune Encephalomyelitis Model

(2012) S. Anwar Jagessar et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis

(2012) J. Pakpoor et al.   Multiple Sclerosis Journal

Gammaherpesvirus Latency Accentuates EAE Pathogenesis: Relevance to Epstein-Barr Virus and Multiple Sclerosis

(2012) Costanza Casiraghi et al.   PLoS Pathogens

Japanese macaque encephalomyelitis: A spontaneous multiple sclerosis-like disease in a nonhuman primate

(2011) Michael K. Axthelm et al.   ANNALS OF NEUROLOGY

Treatment of multiple sclerosis with Anti-CD20 antibodies

(2011) Barbara Barun et al.   CLINICAL IMMUNOLOGY

Unravelling the T-cell-mediated autoimmune attack on CNS myelin in a new primate EAE model induced with MOG34-56peptide in incomplete adjuvant

(2011) S. Anwar Jagessar et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice

(2011) Qing Ding et al.   JOURNAL OF CLINICAL INVESTIGATION

Presentation of Soluble Antigens to CD8+ T Cells by CpG Oligodeoxynucleotide-Primed Human Naive B Cells

(2011) W. Jiang et al.   JOURNAL OF IMMUNOLOGY

B-Cell Depletion Attenuates White and Gray Matter Pathology in Marmoset Experimental Autoimmune Encephalomyelitis

(2011) Yolanda S. Kap et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Breaking Free of Sample Size Dogma to Perform Innovative Translational Research

(2011) P. Bacchetti et al.   Science Translational Medicine

BAFF and selection of autoreactive B cells

(2011) Zheng Liu et al.   TRENDS IN IMMUNOLOGY

EAE: imperfect but useful models of multiple sclerosis

(2011) Bert A. ’t Hart et al.   TRENDS IN MOLECULAR MEDICINE

B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity

(2010) Martin S. Weber et al.   ANNALS OF NEUROLOGY

Late B Cell Depletion with a Human Anti-Human CD20 IgG1  Monoclonal Antibody Halts the Development of Experimental Autoimmune Encephalomyelitis in Marmosets

(2010) Y. S. Kap et al.   JOURNAL OF IMMUNOLOGY

Effects of Early IL-17A Neutralization on Disease Induction in a Primate Model of Experimental Autoimmune Encephalomyelitis

(2010) Yolanda S. Kap et al.   Journal of Neuroimmune Pharmacology

Induction of Progressive Demyelinating Autoimmune Encephalomyelitis in Common Marmoset Monkeys Using MOG34-56Peptide in Incomplete Freund Adjuvant

(2010) S. Anwar Jagessar et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Clinical, Pathological, and Immunologic Aspects of the Multiple Sclerosis Model in Common Marmosets (Callithrix jacchus)

(2009) Bert A. 't Hart et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

EBV in MS: guilty by association?

(2009) Jan D. Lünemann et al.   TRENDS IN IMMUNOLOGY

Multiple sclerosis – a response-to-damage model

(2009) Bert A. ‘t Hart et al.   TRENDS IN MOLECULAR MEDICINE

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

(2008) Benjamin M Segal et al.   LANCET NEUROLOGY